Union Bancaire Privee, Ubp Sa Biomarin Pharmaceutical Inc Transaction History
Union Bancaire Privee, Ubp Sa
- $5.17 Billion
- Q3 2025
A detailed history of Union Bancaire Privee, Ubp Sa transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 3,459 shares of BMRN stock, worth $183,154. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,459Holding current value
$183,154% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
679Shares Held
185MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.01 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$835 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$800 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$651 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.84B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...